News roundup Tuesday, April 4

» Arcede Pharma and Iconovo receive funding from Swelife 
» Interview with Synact Pharma about changes in the company 
» SynAct Pharma makes changes in management 
» Alzinova presented promising data at international conference
» Scandion Oncology's CEO on the expansion into blood cancer

Read BioStock's newsletter for v.13 here.

Yesterday participated ExpreS2ion Biotechnologies of BioStock Investor Pitch. See the presentation below.

Morning news

Cereno Scientific reports that 1/3 of patients have been recruited to a phase II study with CS1. Read more.

Iconovo evaluates ICOone Nasal for the development of an antiviral nasal inhalation product. Read more.

Mendus announces the request from Negma Group on conversion of convertible bonds. Read more.

Lipigon publishes interview with senior researcher stating that the company's method paves the way for more effective treatment for ARDS. Read more.

Swiss hospital buys third Neo100system from Monivent. Read more.

Biovica enters into a commercial partnership for DiviTum TKa in Italy. Read more.

Carbiotix receives loan financing of approximately SEK 4 million. Read more.

BioArctic notes long-term health effects of lecanemab based on a simulation model and data from the phase 3 study Clarity AD. Read more.

Prostatype Genomics announces the outcome of TO 2. Read more.

Scandinavian ChemoTech provides an update regarding pancreatic patients in Ukraine. Read more.

Zenicor decides on a rights issue to finance investments for increased growth. Read more.

Roddenberry Foundation gives Elypta This year's Grand Prize of $1 million. Read more.

SciBase receives a decision on higher reimbursement levels from Medicare in the US for its method for melanoma detection. Read more.

Beactica Therapeutics and Oscotec ends their collaboration. Read more.

Communiqués:

Neodynamics

Annual Reports:

Proby  Promimic  Sedana Medical  XVIVO Perfusion 

Boards:

Spago Nanomedical  Qlife Holding 

Summons:

BICO Group  BioGaia  Camurus  C-Row  Infant Bacterial Therapeutics  Isofol Medical  MedCap  Medistim  Optomed  Prolight Diagnostics  Qlife Holding  Redsense Medical  Sprint Bioscience  Zenicor Medical Systems

Change in votes and equity:

Genmab  Novo Nordisk  Zealand Pharma 

Idogen announced that their cash is expected to last until June and that the company is working on various financing options. Read more.

Stayble Therapeutics vd Andreas Gerward has planned to conduct several presentations and interviews in connection with the ongoing rights issue. Read more.

BiBBInstruments announced that the investor Created  shareholding in the company has been reduced. Read more.

Management personnel in Coegin Pharma has acquired shares. Read more.

Acarix has accelerated commercialization in the US to 30 additional states. Read more.

Double Bond Pharmaceutical International has taken out a bridge loan of SEK 2 million. Read more.

Q-line received first ASTs-orders under new commercialization strategy. Read more.

AcouBlack announced that the stem cell therapy project Blue4Therapy has been completed successfully. Read more.

Intellego signed Term Sheet with LOI partner Heraeus Kina Read more.

Medistim published dividend proposals. Read more.